Mikhail Blagosklonny is a scientist. He focuses his career on studying cancer as well as aging. In addition to being a scientist, he also is a Professor of oncology. He teaches in New York at the Roswell Park Cancer Institute. Read more about Mikhail at LinkedIn
Blagosklonny earned his medical degree as well as his doctorate degree from the First Pavlov State Medical University of St. Peterburg. He received his M.D. in internal medicine and he received his PhD in cardiology and experimental medicine. Before he took a position as a scientist, he became the associate professor of medicine in New York at New York Medical College. He kept this position until he became the professor of Oncology at Roswell Park Cancer Institute. Blagosklonny is very interested in researching cancer as well as different targeted cancer therapies that will protect healthy and normal cells from the damage of cancer treatment. He is also very interested in the mechanisms of aging as well as different anti-aging drugs.
Mikhail Blagosklonny has proposed that using a popular cancer drug, known as rapamycin, this could be a possible treatment for life extension. His passion for research on the longevity of life with rapamycin has made him one of the most passionate advocates. Blagosklonny is very interested in research, and more importantly research on molecular and cellular biology as well as research on clinical investigations for things like tumor suppressors, mitosis, signal transduction, apoptosis and cell cycle. He also focuses on anticancer therapeutics with an emphasis on the translation of basic science that is put into new anticancer strategies. For example, exploiting cancer cell cycling and also drug resistance for a type of selective protection for normal and healthy cells. He has made sure to extend this approach to other age-related diseases, as well.
In addition to his research and teaching, Blagosklonny also has done some editorial work. He is the editor-in-chief of a book called Aging, Cell Cycle, and Oncotarget. In addition to this he is also a member of the editorial board for Cell Death and Differentiation. He also holds the position as associate editor of Cancer Biology and Therapy. He has also published 300 different research articles, book chapters and also reviews. View Mikhail’s profile on Loop